SUBSCRIBE
SUBSCRIBE

Press Releases

Browse the the latest press releases from around the industry. Want to filter press releases by date, keyword, and more? Search here.

THE LATEST
Press Releases
Calla Lily Clinical Care and Merck Announce Strategic Collaboration to Advance Intravaginal Drug Delivery Platform
February 10, 2026
 · 
3 min read
Press Releases
U.S. Food and Drug Administration Accepts New Drug Application and Grants Priority Review for Takeda’s Oveporexton (TAK-861) as a Potential First-in-Class Therapy for Narcolepsy Type 1
February 10, 2026
 · 
8 min read
Press Releases
ArrayPatch Announces First Close of €3M Seed Round to Advance ITZ-DerMap™ for Treatment of Nail Fungus
February 10, 2026
 · 
2 min read
Press Releases
Kainova Therapeutics Secures $32M CAD to Accelerate Development of Immuno-Oncology and Inflammation Therapies
February 10, 2026
 · 
4 min read
Press Releases
The 15-20 National Hospital and GenSight Biologics Announce the Treatment of the First Patient in the GS010/LUMEVOQ® REVISE Study
February 10, 2026
 · 
5 min read
Press Releases
4Moving Biotech Announces the Closing of a €12 Million Financing to Advance a First-in-Class DMOAD in Knee Osteoarthritis
February 10, 2026
 · 
2 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Issue of Equity
February 10, 2026
 · 
5 min read
Press Releases
Philips delivers full year 2025 with growth acceleration, strong margin expansion and solid cash flow; announces 2026-2028 targets at Capital Markets Day
February 10, 2026
 · 
14 min read
Press Releases
Santhera Appoints Stifel as Corporate Finance Advisor
February 10, 2026
 · 
2 min read
Press Releases
Philips proposes to re-appoint CEO Roy Jakobs
February 10, 2026
 · 
2 min read
Press Releases
Simulations Plus Announces Extensions of U.S. FDA and NIEHS Research Collaborations
February 10, 2026
 · 
5 min read
Press Releases
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, February 25, 2026
February 10, 2026
 · 
1 min read
Press Releases
Satellos Closes US$57.2 Million Public Offering in Canada and the United States, Including Exercise of Underwriters’ Option to Purchase Additional Shares
February 10, 2026
 · 
4 min read
Press Releases
Amentum Reports First Quarter Fiscal Year 2026 Results and Reaffirms Full Year Guidance
February 10, 2026
 · 
19 min read
Press Releases
Johnson & Johnson to Participate in the Barclays 28th Annual Global Healthcare Conference
February 10, 2026
 · 
1 min read
Press Releases
Medpace Holdings, Inc. Reports Fourth Quarter and Full Year 2025 Results
February 10, 2026
 · 
18 min read
Press Releases
Vir Biotechnology to Host Conference Call for Fourth Quarter and Full Year 2025 Financial Results
February 10, 2026
 · 
1 min read
Press Releases
Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025
February 10, 2026
 · 
13 min read
Press Releases
Forte Biosciences, Inc. to Present at Upcoming Investor Meetings - February 9, 2026
February 10, 2026
 · 
1 min read
Press Releases
Kaiser Permanente names Mike Bowers president of Northern California Region
February 10, 2026
 · 
2 min read
Press Releases
DBV Technologies to Participate in the Guggenheim Securities Emerging Outlook: Biotech Summit
February 10, 2026
 · 
2 min read
Press Releases
Azenta Life Sciences and Frontier Space Announce Strategic Partnership to Advance Space-Based Life Sciences Research Infrastructure
February 10, 2026
 · 
4 min read
Press Releases
Nektar to Hold Conference Call to Discuss Topline Results from the 36-Week Maintenance Period for its REZOLVE-AD Phase 2b Study of Rezpegaldesleukin in Atopic Dermatitis on February 10, 2026
February 10, 2026
 · 
2 min read
Press Releases
C4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) - February 9, 2026
February 10, 2026
 · 
1 min read
Press Releases
Praxis Precision Medicines to Report Fourth Quarter and Full Year 2025 Financial Results on Thursday, February 19, 2026, and Participate in Upcoming Investor Conferences
February 10, 2026
 · 
2 min read
Press Releases
Agomab Announces Closing of Initial Public Offering
February 10, 2026
 · 
4 min read
Press Releases
SpyGlass Pharma Announces Closing of Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
February 10, 2026
 · 
3 min read
Press Releases
LifeStance to Host Fourth Quarter and Full Year 2025 Earnings Conference Call on February 25, 2026
February 10, 2026
 · 
1 min read
Press Releases
OraSure to Announce Fourth Quarter 2025 Financial Results and Host Earnings Call on February 25th
February 10, 2026
 · 
1 min read
Press Releases
Agenus to Present New Data at AACR-IO Exploring Systemic and Tumor Inflammation Biomarkers with BOT/BAL in Immunologically Cold Tumors
February 10, 2026
 · 
4 min read
Press Releases
National Organization for Rare Disorders Ranks All 50 States on Rare Disease Policies
February 10, 2026
 · 
4 min read
Press Releases
PharmaEssentia Announces Plans to Establish New U.S. Manufacturing Facility in Puerto Rico to Support Global Growth of BESREMi®
February 10, 2026
 · 
6 min read
Press Releases
BillionToOne Announces Dual Launch of UNITY Expanded Red Blood Cell and Platelet Fetal Antigen NIPTs, Extending Its Leadership In Setting the New Standard in Prenatal Care
February 10, 2026
 · 
6 min read
Press Releases
AB Science announced that the Food and Drug Administration (FDA) granted the status of Minor Use in Major Species (MUMS) for Masivet® in the treatment of canine mast cell tumors
February 10, 2026
 · 
4 min read
Load More